Chestnykh, D., Mühle, C., Schumacher, F., Kalinichenko, L. S., Löber, S., Gmeiner, P., . . . Müller, C. P. (2025). Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia. Molecular psychiatry, 30(7), . https://doi.org/10.1038/s41380-025-02893-6
Chicago-Zitierstil (17. Ausg.)Chestnykh, Daria, et al. "Acid Sphingomyelinase Activity Suggests a New Antipsychotic Pharmaco-treatment Strategy for Schizophrenia." Molecular Psychiatry 30, no. 7 (2025). https://doi.org/10.1038/s41380-025-02893-6.
MLA-Zitierstil (9. Ausg.)Chestnykh, Daria, et al. "Acid Sphingomyelinase Activity Suggests a New Antipsychotic Pharmaco-treatment Strategy for Schizophrenia." Molecular Psychiatry, vol. 30, no. 7, 2025, https://doi.org/10.1038/s41380-025-02893-6.